POINT Biopharma Global Inc.
NASDAQ:PNT
12.5 (USD) • At close December 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||
| Current Assets: | |||||||||||||||
| Cash & Cash Equivalents
| 21.607 | 57.293 | 111.14 | 286.428 | 125.783 | 78.108 | 227.385 | 238.816 | 252.826 | 273.737 | 0.7 | 10.547 | 1.141 | 0 | 0.025 |
| Short Term Investments
| 317.556 | 365.933 | 318.894 | 238.783 | 165.736 | 121.324 | 0 | 0 | 0 | 0 | 135.706 | 135,706.395 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 339.163 | 423.226 | 430.033 | 525.212 | 291.519 | 199.433 | 227.385 | 238.816 | 252.826 | 273.737 | 0.7 | 10.547 | 1.141 | 0 | 0.025 |
| Net Receivables
| 9.388 | 3.732 | 0.159 | 0.06 | 0.17 | 0.143 | 0.09 | 0.073 | 0.049 | 0.031 | 0 | 0.059 | 0 | 0 | 0 |
| Inventory
| 4.203 | 5.2 | 4.198 | 5.335 | 4.322 | 5.138 | 4.866 | 4.852 | 6.247 | 7.976 | 0 | 1.764 | 0 | 0 | 0 |
| Other Current Assets
| 0.493 | 0.217 | 0.189 | 0.215 | 0.221 | 0.191 | 0.272 | 0.105 | 0.173 | 0.065 | 0.089 | 0.028 | 0.124 | 0 | 0 |
| Total Current Assets
| 353.247 | 432.375 | 434.58 | 530.823 | 296.231 | 204.905 | 232.614 | 243.847 | 259.294 | 281.808 | 0.788 | 12.397 | 1.265 | 0 | 0.025 |
| Non-Current Assets: | |||||||||||||||
| Property, Plant & Equipment, Net
| 59.548 | 48.8 | 34.774 | 31.381 | 29.457 | 24.441 | 20.368 | 19.412 | 17.902 | 15.654 | 0 | 9.797 | 0 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 59.793 | 11.571 | 89.17 | 16.119 | 0 | 4.898 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 5.117 | 5.029 | -123.944 | -47.5 | -29.457 | 0 | 0 | 0 | 0 | 0 | 135.71 | 0 | 135.703 | 0 | 0.09 |
| Total Non-Current Assets
| 124.458 | 65.399 | 123.944 | 47.5 | 29.457 | 29.34 | 20.368 | 19.412 | 17.902 | 15.654 | 135.71 | 9.797 | 135.703 | 0 | 0.09 |
| Total Assets
| 477.704 | 497.775 | 558.524 | 578.323 | 325.688 | 234.245 | 252.982 | 263.259 | 277.196 | 297.463 | 136.498 | 22.194 | 136.968 | 0 | 0.115 |
| Liabilities & Equity: | |||||||||||||||
| Current Liabilities: | |||||||||||||||
| Account Payables
| 8.887 | 13.9 | 15.919 | 7.677 | 3.199 | 8.067 | 6.12 | 1.738 | 3.218 | 5.018 | 0.353 | 3.596 | 0.005 | 0 | 0 |
| Short Term Debt
| 1.927 | 1.257 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.556 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0.737 | 1.452 | 28.795 | 29.699 | 0.362 | 0.509 | 0.329 | 0.251 | 0.202 | 0.189 | 0 | 0.088 | 0 | 0 | 0 |
| Deferred Revenue
| 12.586 | 15.9 | 16.519 | 23.242 | 0 | 0 | 0 | 0 | 0 | 0.189 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 15.266 | 10.099 | 45.41 | 48.82 | 13.409 | 10.73 | 7.523 | 6.241 | 4.876 | 3.146 | 5.504 | 1.568 | 0.047 | 0 | 0.102 |
| Total Current Liabilities
| 38.666 | 41.156 | 77.848 | 79.738 | 16.608 | 18.797 | 13.643 | 7.98 | 8.094 | 11.91 | 5.857 | 5.164 | 0.052 | 0 | 0.102 |
| Non-Current Liabilities: | |||||||||||||||
| Long Term Debt
| 8.736 | 4.517 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.551 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 3.721 | 3.198 | 7.444 | 10.178 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0.066 | 0.066 | 0.066 | 0.063 | 0.063 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 2.389 | 1.452 | 1.452 | 1.452 | 3.199 | 0 | 0 | 0 | 0 | 0 | 4.75 | 0 | 4.75 | 0 | 0 |
| Total Non-Current Liabilities
| 14.846 | 9.167 | 8.897 | 11.631 | 3.199 | 0.066 | 0.066 | 0.066 | 0.063 | 0.063 | 4.75 | 3.551 | 4.75 | 0 | 0 |
| Total Liabilities
| 53.512 | 50.323 | 86.744 | 91.369 | 16.608 | 18.862 | 13.708 | 8.046 | 8.157 | 11.972 | 5.857 | 8.714 | 4.801 | 0 | 0.102 |
| Equity: | |||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.011 | 0.011 | 0.011 | 0.011 | 0.01 | 0.009 | 0.009 | 0.009 | 0.009 | 0.009 | 125.642 | 0.005 | 127.167 | 0 | 0 |
| Retained Earnings
| -27.707 | -2.933 | 22.478 | 39.009 | -124.259 | -100.246 | -75.665 | -59.285 | -45.088 | -27.971 | -1.711 | -13.382 | -0.185 | 0 | -0.012 |
| Accumulated Other Comprehensive Income/Loss
| -1.431 | -1.069 | -0.256 | -0.457 | -0.609 | -0.342 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 453.32 | 451.443 | 449.547 | 448.392 | 433.937 | 315.961 | 314.93 | 314.489 | 314.118 | 313.453 | 6.71 | 26.857 | 5.184 | 0 | 0.025 |
| Total Shareholders Equity
| 424.192 | 447.452 | 471.78 | 486.954 | 309.08 | 215.382 | 239.274 | 255.213 | 269.039 | 285.49 | 130.641 | 13.48 | 132.167 | 0 | 0.013 |
| Total Equity
| 424.192 | 447.452 | 471.78 | 486.954 | 309.08 | 215.382 | 239.274 | 255.213 | 269.039 | 285.49 | 130.641 | 13.48 | 132.167 | 0 | 0.013 |
| Total Liabilities & Shareholders Equity
| 477.704 | 497.775 | 558.524 | 578.323 | 325.688 | 234.245 | 252.982 | 263.259 | 277.196 | 297.463 | 136.498 | 22.194 | 136.968 | 0 | 0.115 |